Galderma Group AG Logo

Galderma Group AG

GALD | SW

Overview

Corporate Details

ISIN(s):
CH1335392721
LEI:
89450001OK6O8ELQ4584
Country:
Switzerland
Address:
Zählerweg 10, 6300 Zug
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Galderma Group AG is a pure-play dermatology company dedicated to advancing skin health. With a legacy of over 40 years of science-based innovation, Galderma offers a comprehensive portfolio of premium brands and services with a presence in approximately 90 countries. The company's operations are structured across three key business units: Injectable Aesthetics, providing aesthetic solutions; Dermatological Skincare, which includes consumer health products; and Therapeutic Dermatology, focused on prescription medications for various skin conditions. Formerly a subsidiary of Nestlé and L'Oréal, the company is committed to delivering cutting-edge solutions that meet the full spectrum of individual skin needs.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Galderma Group AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Galderma Group AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Galderma Group AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-31 N/A Non-Executive member Sell None 935,664.75 CHF
2025-03-28 N/A Non-Executive member Sell None 1,876,958.07 CHF
2025-03-27 N/A Non-Executive member Sell None 265,440.84 CHF
2025-03-26 N/A Non-Executive member Sell None 673,175.70 CHF
2025-03-25 N/A Executive member Buy None 243,205.38 CHF
2025-03-20 N/A Non-Executive member Sell None 1,156,106.24 CHF
2025-03-20 N/A Non-Executive member Sell None 47,702.12 CHF
2025-03-17 N/A Executive member Sell None 7,962,599.99 CHF
2024-12-20 N/A Non-Executive member Sell None 105,831.00 CHF
2024-11-06 N/A Non-Executive member Sell None 177,500.00 CHF

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK